• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AGEN:US

3.0500 USD 0.00000.00%

As of 10:20:40 ET on 07/23/2014.

Snapshot for Agenus Inc (AGEN)

Open: 3.0600 Day's Range: 3.0100 - 3.1600 Volume: 181,487
Previous Close: 3.0500 52wk Range: 2.2700 - 5.2690 1-Yr Rtn: -20.16%

Stock Chart for AGEN

No chart data available.
  • AGEN:US 3.0500
  • 1D
  • 1M
  • 1Y
3.0500
Interactive AGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AGEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7900
Est. EPS (USD) (12/2014) -0.5670
Est. PEG Ratio -
Market Cap (M USD) 189.82
Shares Outstanding (M) 62.24
30 Day Average Volume 1,382,599
Price/Book (mrq) 6.1297
Price/Sale (ttm) 38.8420
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AGEN

Agenus, Inc. develops vaccines. The Company researches vaccines for brain cancer, kidney cancer, herpes, lung cancer, melanoma, malaria, shingles, and Alzheimer's disease.

Garo H ArmenChairman/CEO/Co-FounderRobert B Stein "Bob"Chief Scientific Officer
Ozer BaysalChief Business OfficerKaren H ValentineVP/Chief Compliance Ofcr/Secy
More Company Profile & Key Executives for AGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil